Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia

Document type :
Journal articles
Complete list of metadatas

https://hal-clermont-univ.archives-ouvertes.fr/hal-01860422
Contributor : Dominique Chadeyron <>
Submitted on : Thursday, August 23, 2018 - 1:58:59 PM
Last modification on : Friday, March 15, 2019 - 12:44:39 PM

Links full text

Identifiers

Citation

Pierre Feugier, Thérèse Aurran, Beatrice Mahe, Remi Letestu, Florence Nguyen-Khac, et al.. Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia. Haematologica, Ferrata Storti Foundation, 2018, 103 (7), pp.e304 - e306. ⟨10.3324/haematol.2017.183350⟩. ⟨hal-01860422⟩

Share

Metrics

Record views

42